In a difficult climate for capital raisings, biotechs are turning to loans backed by their expected research and development tax refunds.

From your kitchen to the backyard, the spring vibes in your home are about to be immaculate. View Entire Post › ...

Jabil benefits from minimal tariff impact due to its B2B model, often passing costs to end-product companies. Check out why I ...

Greetings and welcome to the Helen of Troy Fourth Quarter Fiscal 2025 Earnings Conference Call. At this time, all ...

Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...

Asthma inhalers are a vital tool to help manage the common lung condition, but medics have warned that some users of blue inhalers are not using them correctly. Blue inhalers, also known as ...

Medics have warned that some asthma sufferers using blue inhalers could be putting their health at risk. More than seven million Brits are living with asthma, according to Asthma and Lung UK.

Most of these will have a mixture of inhalers to combat the condition. These include a "preventer" inhaler taken daily to help stop attacks from happening and a use a reliever inhaler, which is ...

People with asthma are being warned they are at increased risk of severe asthma attacks if they just rely on blue inhalers. Blue reliever inhalers act quickly to treat symptoms and attacks and people ...